These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31233736)

  • 1. Free light chains in cerebrospinal fluid of multiple sclerosis patients negative for IgG oligoclonal bands.
    Altinier S; Puthenparampil M; Zaninotto M; Toffanin E; Ruggero S; Gallo P; Plebani M
    Clin Chim Acta; 2019 Sep; 496():117-120. PubMed ID: 31233736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free Kappa light chains in neuroinflammatory disorders: Complement rather than substitute?
    Bayart JL; Muls N; van Pesch V
    Acta Neurol Scand; 2018 Oct; 138(4):352-358. PubMed ID: 29900542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of cerebrospinal fluid kappa free light chains with the intrathecal polyspecific antiviral immune response in multiple sclerosis.
    Huss A; Mojib-Yezdani F; Bachhuber F; Fangerau T; Lewerenz J; Otto M; Tumani H; Senel M
    Clin Chim Acta; 2019 Nov; 498():148-153. PubMed ID: 31437445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Use of κ Free Light Chains Index as a Screening Test for Multiple Sclerosis.
    Agnello L; Lo Sasso B; Salemi G; Altavilla P; Pappalardo EM; Caldarella R; Meli F; Scazzone C; Bivona G; Ciaccio M
    Lab Med; 2020 Jul; 51(4):402-407. PubMed ID: 31943078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal K free light chain synthesis in multiple sclerosis at clinical onset associates with local IgG production and improves the diagnostic value of cerebrospinal fluid examination.
    Puthenparampil M; Altinier S; Stropparo E; Zywicki S; Poggiali D; Cazzola C; Toffanin E; Ruggero S; Grassivaro F; Zaninotto M; Plebani M; Gallo P
    Mult Scler Relat Disord; 2018 Oct; 25():241-245. PubMed ID: 30130707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inter-assay diagnostic accuracy of cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis.
    Dekeyser C; De Kesel P; Cambron M; Vanopdenbosch L; Van Hijfte L; Vercammen M; Laureys G
    Front Immunol; 2024; 15():1385231. PubMed ID: 38745673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid kappa and lambda free light chains in oligoclonal band-negative patients with suspected multiple sclerosis.
    Ferraro D; Trovati A; Bedin R; Natali P; Franciotta D; Santangelo M; Camera V; Vitetta F; Varani M; Trenti T; Gastaldi M; De Biasi S; Nasi M; Pinti M; Meletti S; Sola P
    Eur J Neurol; 2020 Mar; 27(3):461-467. PubMed ID: 31710409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High sensitivity and specificity of elevated cerebrospinal fluid kappa free light chains in suspected multiple sclerosis.
    Hassan-Smith G; Durant L; Tsentemeidou A; Assi LK; Faint JM; Kalra S; Douglas MR; Curnow SJ
    J Neuroimmunol; 2014 Nov; 276(1-2):175-9. PubMed ID: 25146968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kappa Free Light Chains and IgG Combined in a Novel Algorithm for the Detection of Multiple Sclerosis.
    Gudowska-Sawczuk M; Tarasiuk J; Kułakowska A; Kochanowicz J; Mroczko B
    Brain Sci; 2020 May; 10(6):. PubMed ID: 32471086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis.
    Gaetani L; Di Carlo M; Brachelente G; Valletta F; Eusebi P; Mancini A; Gentili L; Borrelli A; Calabresi P; Sarchielli P; Ferri C; Villa A; Di Filippo M
    J Neuroimmunol; 2020 Feb; 339():577108. PubMed ID: 31743879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis-from diagnosis to prediction of disease activity.
    Hegen H; Berek K; Deisenhammer F
    Wien Med Wochenschr; 2022 Nov; 172(15-16):337-345. PubMed ID: 35133530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexes.
    Gurtner KM; Shosha E; Bryant SC; Andreguetto BD; Murray DL; Pittock SJ; Willrich MAV
    Clin Chem Lab Med; 2018 Jun; 56(7):1071-1080. PubMed ID: 29455184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution.
    Beseler C; Vollmer T; Graner M; Yu X
    PLoS One; 2017; 12(10):e0186842. PubMed ID: 29059249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligoclonal free light chains in cerebrospinal fluid as markers of intrathecal inflammation. Comparison with oligoclonal IgG.
    Zeman D; Hradilek P; Kusnierova P; Piza R; Reguliova K; Woznicova I; Zapletalova O
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Mar; 159(1):104-13. PubMed ID: 25485529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status.
    Balnytė R; Rastenytė D; Vaitkus A; Skrodenienė E; Vitkauskienė A; Ulozienė I
    Medicina (Kaunas); 2016; 52(4):217-222. PubMed ID: 27515835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The elusive nature of the oligoclonal bands in multiple sclerosis.
    Kennedy PGE; George W; Yu X
    J Neurol; 2024 Jan; 271(1):116-124. PubMed ID: 37945762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of κFLC and κ Index in cerebrospinal fluid: a valid alternative to assess intrathecal immunoglobulin synthesis.
    Duranti F; Pieri M; Centonze D; Buttari F; Bernardini S; Dessi M
    J Neuroimmunol; 2013 Oct; 263(1-2):116-20. PubMed ID: 23916392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid free kappa light chains and kappa index perform equal to oligoclonal bands in the diagnosis of multiple sclerosis.
    Christiansen M; Gjelstrup MC; Stilund M; Christensen T; Petersen T; Jon Møller H
    Clin Chem Lab Med; 2018 Dec; 57(2):210-220. PubMed ID: 30055097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: a longitudinal study.
    Mancuso R; Franciotta D; Rovaris M; Caputo D; Sala A; Hernis A; Agostini S; Calvo M; Clerici M
    Mult Scler; 2014 Dec; 20(14):1900-3. PubMed ID: 24948690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis.
    Schwenkenbecher P; Konen FF; Wurster U; Jendretzky KF; Gingele S; Sühs KW; Pul R; Witte T; Stangel M; Skripuletz T
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30501024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.